These values are the geometric mean percentage change from baseline.
For all participants we used the geometric mean percentage of change from baseline, with 95% confidence intervals.
In the total population, a significant (p<0.05) geometric mean percentage change in IFNγ gene expression of −52%95%5% CI −73 to −15) was observed (fig 2A).
Data presented as the geometric means (percentage of the coefficient of variation. N/A: not applicable. aSubjects in Group A did not receive abatacept. bSubjects in Group B received abatacept at 14 days (serum concentration taken pre-abatacept dosing).
The adjusted geometric mean percentage of men with morphological normal sperm differed up to 15% among regions with lowest values in Warsaw and highest values in Sweden (Table 7).
In pooled results for women receiving continuous odanacatib (10 50 mg, n = 26 29), the year 5 geometric mean percentage changes from baseline in the bone resorption markers NTX/Cr and CTX were approximately −55 %, but the values for the bone formation markers bone-specific alkaline phosphatase and procollagen type I N-propeptide were near baseline.
Generalized linear models were used to estimate least-squares arithmetic and geometric mean percentages of breast density for each genotype.
However, the geometric mean percentages (90% confidence intervals) of the combination/alone ratio for the logarithmically transformed values of chloroquine Cmax, AUC0-last, and AUC0-∞ were 103%92.1%1% to 116%), 104% (95.4% to 114%), and 106% (97.7% to 115%), respectively (Table 4 and Fig. 2).
The geometric mean percentages (90% confidence intervals) of the combination/alone ratios for the logarithmically transformed values of carboxyprimaquine Cmax, AUC0 last, and AUC0-∞ were 109% (104 to 115%), 104% (98.6 to 111%), and 98.1% (93.0 to 104%), respectively (Table 4 and Fig. 2).
The geometric mean percentages (90% confidence intervals) of the combination/alone ratios for the logarithmically transformed values of primaquine Cmax, AUC0 last, and AUC0 ∞ were 130% (117 to 146%), 115% (107 to 125%), and 115% (106 to 124%), respectively (Table 4 and Fig. 2).
